Wednesday, February 27, 2019

Lupin launches chronic angina treatment drug in the US

Lupin launches chronic angina treatment drug in the US The newly launched product, in strengths of 500 mg and 1,000 mg, is a generic version of Gilead Sciences#39; Ranexa ER tablets.

from Moneycontrol Business News https://ift.tt/2VsUBml

No comments:

Post a Comment

Adani Group stocks slide up to 14% on US SEC heat

Adani Group stocks saw a sharp decline on Friday. This followed news that the US SEC is seeking court permission to email summons to founder...